MAHINDRA MANULIFE LARGE & MIDCAP FUND
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks

Data as on 31st December 2025

Investment Objective The investment objective of the Scheme is to seek long term capital growth through investments in equity and equity related securities of both large cap and mid cap stocks. However, there can be no assurance that the investment objective of the Scheme will be achieved.
Fund Features Rule based diversification for optimum performance in changing market cycles
Aim to provide stability of large caps and growth of mid caps
Active stock selection through internal process framework for better return potential
Fund Manager and Experience Fund Manager: Ms. Kirti Dalvi
Total Experience: 18 years
Experience in managing this fund: 1 month (Managing since December 02, 2025)
Date of allotment December 30, 2019
Benchmark NIFTY Large Midcap 250 TRI
Options IDCW (IDCW Option will have IDCW Reinvestment (D) & IDCW Payout facility) and Growth (D)
D-Default
Minimum Application Amount Rs. 1,000 and in multiples of Re. 1/- thereafter
Minimum Amount for Redemption / Switch-outs: Rs. 1,000/- or 100 units or account balance, whichever is lower in respect of each Option.
SIP Minimum Weekly & Monthly SIP Amount: Rs 500 and in multiples of Re 1 thereafter
Minimum Weekly & Monthly SIP Installments: 6
Minimum Quarterly SIP Amount: Rs 1,500 and in multiples of Re 1 thereafter
Minimum Quarterly SIP installments: 4
Monthly AAUM as on December 31, 2025 (Rs. in Cr.): 2,759.11
Quarterly AAUM as on December 31, 2025 (Rs. in Cr.): 2763.86
Monthly AUM as on December 31, 2025 (Rs. in Cr.): 2,776.86
Total Expense Ratio1 as on December 31, 2025: Regular Plan: 1.91%
Direct Plan: 0.45%
1Includes additional expenses charged in terms of Regulation 52 (6A) (b) and 52 (6A) (c) of SEBI (Mutual Funds) Regulations, 1996 and Goods and Services Tax.
Load Structure: Entry Load: N.A.
Exit Load: An Exit Load of 1% is payable if Units are redeemed / switched-out upto 3 months from the date of allotment;
Nil if Units are redeemed / switched-out after 3 months from the date of allotment.

Portfolio Turnover Ratio (Last 1 year): 1.11
Standard Deviation: 13.45%
Beta: 0.93
Sharpe Ratio#: 0.80
Jenson’s Alpha : -0.1433
#Risk-free rate assumed to be 5.67% (MIBOR as on 31-12-2025). Source: www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns for last 3 years. Data as on December 31, 2025

NAV as on December 31, 2025
NAV/Unit
Regular Plan (In Rs.)
Direct Plan (In Rs.)
IDCW
20.8056
23.5158
Growth
27.2844
30.2662
IDCW: Income Distribution cum Capital Withdrawal.

Company / Issuer
% of Net Assets
Automobile And Auto Components
7.63%
Bajaj Auto Limited
1.52%
Bosch Limited
1.51%
Mahindra & Mahindra Limited
1.46%
Maruti Suzuki India Limited
1.32%
Amara Raja Energy & Mobility Ltd
1.07%
Tube Investments of India Limited
0.75%
Capital Goods
6.20%
Bharat Heavy Electricals Limited
1.55%
Bharat Electronics Limited
1.12%
Polycab India Limited
1.03%
PTC Industries Limited
0.96%
Kaynes Technology India Limited
0.61%
Hindustan Aeronautics Limited
0.55%
Technocraft Industries (India) Limited
0.38%
Chemicals
2.51%
SRF Limited
1.09%
Aarti Industries Limited
0.71%
Solar Industries India Limited
0.71%
Construction Materials
4.10%
UltraTech Cement Limited
3.03%
Dalmia Bharat Limited
1.07%
Consumer Durables
1.91%
Kajaria Ceramics Limited
1.13%
Blue Star Limited
0.78%
Consumer Services
2.18%
Vishal Mega Mart Limited
0.83%
Swiggy Limited
0.71%
ITC Hotels Limited
0.64%
Fast Moving Consumer Goods
0.29%
Dabur India Limited
0.29%
Financial Services
27.99%
ICICI Bank Limited
3.26%
State Bank of India
2.72%
Axis Bank Limited
2.51%
Bajaj Finserv Limited
2.46%
IndusInd Bank Limited
2.21%
IDFC First Bank Limited
2.19%
The Federal Bank Limited
2.16%
Indian Bank
1.60%
ICICI Lombard General Insurance Company Limited
1.39%
IIFL Finance Limited
1.26%
Shriram Finance Limited
1.19%
HDFC Asset Management Company Limited
1.19%
CRISIL Limited
0.99%
Angel One Limited
0.96%
Cholamandalam Financial Holdings Limited
0.78%
Aditya Birla Sun Life AMC Limited
0.62%
Central Depository Services (India) Limited
0.48%
ICICI Prudential Asset Management Company Limited
0.02%
Healthcare
15.43%
Glenmark Pharmaceuticals Limited
3.29%
Divi's Laboratories Limited
2.88%
Laurus Labs Limited
2.11%
Senores Pharmaceuticals Limited
1.60%
Neuland Laboratories Limited
1.52%
Aurobindo Pharma Limited
1.28%
Apollo Hospitals Enterprise Limited
0.99%
IPCA Laboratories Limited
0.91%
Mankind Pharma Limited
0.85%
Information Technology
11.13%
Infosys Limited
2.64%
Tech Mahindra Limited
2.23%
Persistent Systems Limited
2.09%
Mphasis Limited
1.68%
LTIMindtree Limited
1.52%
Wipro Limited
0.97%
Metals & Mining
2.20%
JSW Steel Limited
2.20%
Oil Gas & Consumable Fuels
3.61%
Reliance Industries Limited
2.91%
Coal India Limited
0.70%
Others
1.80%
Mahindra Manulife Liquid Fund -Direct Plan -Growth
1.80%
Power
2.18%
JSW Energy Limited
1.13%
Torrent Power Limited
1.05%
Realty
2.52%
DLF Limited
1.65%
Sri Lotus Developers and Realty Ltd.
0.87%
Services
0.99%
InterGlobe Aviation Limited
0.99%
Telecommunication
5.27%
Indus Towers Limited
4.19%
Bharti Hexacom Limited
1.08%
Equity and Equity Related Total
97.94%
Cash & Other Receivables
2.06%
Grand Total
100.00%
( Top Ten Holdings - Issuer wise) as on December 31, 2025

Mahindra Manulife

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 30-Dec-19.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular and Direct Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. Ms. Kirti Dalvi is managing this scheme since December 2, 2025.
For performance details of other schemes managed by the Fund Manager(s), please click here | Best Viewed in Landscape mode

Mahindra Manulife

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 30-Dec-19. Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
For SIP Performance please click here | Best Viewed in Landscape mode

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA

As per the latest Market Capitalisation data provided by AMFI (In line with the applicable SEBI guidelines)

Record Date
Plan(s) / Option(s)
IDCW
Face Value
Cum-IDCW NAV
(Rs. per unit)
(Rs. per unit)
(Rs. per unit)
27-Feb-23
Regular IDCW
1.00
10
15.2452
27-Feb-23
Direct IDCW
1.00
10
16.2458
14-Mar-24
Regular IDCW
1.00
10
21.3916
14-Mar-24
Direct IDCW
1.00
10
23.2934
13-Mar-25
Regular IDCW
1.00
10
18.8131
13-Mar-25
Direct IDCW
1.00
10
20.8901

IDCW: Income Distribution cum Capital Withdrawal.
Pursuant to payment of IDCW, the NAV of the IDCW Option(s) of the Scheme/Plan(s) falls to the extent of payout and statutory levy, if any. Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments.
For complete list of IDCWs, visit www.mahindramanulife.com.

Product Suitability
This Product is Suitable for investors who are seeking*
  • Long term wealth creation and income
  • Investment predominantly in equity and equity related securities of large and mid cap companies
Scheme Riskometers
Benchmark Riskometers

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA
As per AMFI Tier I Benchmark i.e. Nifty Large Midcap 250 TRI
* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.